Landscapes / Targets
M1 muscarinic receptor
3 drugs act on M1 muscarinic receptor, in 26 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Bristol Myers Squibb · Public BMY |
Approved | 24 Nov 2026soonPhase 3 trial completes | ||
| Next date | 24 Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Schizophrenia, Alzheimer Disease and 11 more | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Schizophrenia | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Alzheimer Disease | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 3 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026